Implementing an Antimicrobial Stewardship Program in an Oncology Center in Lima, Peru: A Model for Low- and Middle-Income Countries
Authors:
Open Access
- 12 July 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 11 (8) , ofae402
Abstract
Our center launched the first antimicrobial stewardship program in Peru. From 2016 to 2023, the proportion of antimicrobial prescriptions audited increased from 60% to 95%, and 65% to 95% of recommendations were accepted. Vancomycin and meropenem use dropped by 95% and 84%, respectively. The proportion of recommendations for surgical prophylaxis exceeded 90%.Keywords
Funding Information
- Auna Peru
This publication has 15 references indexed in Scilit:
- The use of routinely collected electronic prescribing data to benchmark intravenous antibiotic use between two tertiary paediatric haematology-oncology inpatient units: a retrospective studyJAC-Antimicrobial Resistance, 2023
- Improving antimicrobial use through better diagnosis: The relationship between diagnostic stewardship and antimicrobial stewardshipInfection Control & Hospital Epidemiology, 2023
- Individualized Antibiotic Plans as a Quality Improvement Initiative to Reduce Carbapenem Use for Hematopoietic Cell Transplant Patients at a Freestanding Pediatric HospitalClinical Infectious Diseases, 2023
- Challenges and Opportunities in Antimicrobial Stewardship among Hematopoietic Stem Cell Transplant and Oncology PatientsAntibiotics, 2023
- Procedure-Level Misutilization of Antimicrobial Prophylaxis in Pediatric Surgery: Implications for Improved Stewardship and More Effective Infection PreventionJournal of Pediatric Surgery, 2023
- Implementation of an antimicrobial stewardship program in the Australian private hospital system: qualitative study of attitudes to antimicrobial resistance and antimicrobial stewardshipBMC Health Services Research, 2022
- Antibiotic review kit for hospitals (ARK-Hospital): a stepped-wedge cluster-randomised controlled trialThe Lancet Infectious Diseases, 2022
- Bacterial profile and antimicrobial susceptibility patterns in cancer patientsPLOS ONE, 2022
- Infection control issues in patients with haematological malignancies in the era of multidrug-resistant bacteriaThe Lancet Oncology, 2014
- Antimicrobial Stewardship in Patients with CancerPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2012